188 related articles for article (PubMed ID: 31758500)
1. Mild polypharmacy and MCI progression in older adults: the mediation effect of drug-drug interactions.
Trevisan C; Limongi F; Siviero P; Noale M; Cignarella A; Manzato E; Sergi G; Maggi S
Aging Clin Exp Res; 2021 Jan; 33(1):49-56. PubMed ID: 31758500
[TBL] [Abstract][Full Text] [Related]
2. Anticholinergic Burden, Polypharmacy, and Cognition in Parkinson's Disease Patients with Mild Cognitive Impairment: A Cross-Sectional Observational Study.
Sumbul-Sekerci B; Bilgic B; Pasin O; Emre M; Hanagasi HA
Dement Geriatr Cogn Disord; 2022; 51(5):386-395. PubMed ID: 36273437
[TBL] [Abstract][Full Text] [Related]
3. Anticholinergic Drug Burden and Risk of Incident MCI and Dementia: A Population-based Study.
Gildengers A; Stoehr GP; Ran X; Jacobsen E; Teverovsky E; Chang CH; Ganguli M
Alzheimer Dis Assoc Disord; 2023 Jan-Mar 01; 37(1):20-27. PubMed ID: 36706325
[TBL] [Abstract][Full Text] [Related]
4. Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.
Wu YH; Wang CJ; Hung CH; Chen LY; Lin MH; Wang PN; Chen LK
Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():57-64. PubMed ID: 28436193
[TBL] [Abstract][Full Text] [Related]
5. Anticholinergic Burden and Functional Status in Older People with Cognitive Impairment: Results from the Regal Project.
Boccardi V; Baroni M; Paolacci L; Ercolani S; Longo A; Giordano M; Ruggiero C; Mecocci P
J Nutr Health Aging; 2017; 21(4):389-396. PubMed ID: 28346565
[TBL] [Abstract][Full Text] [Related]
6. Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis.
Pieper NT; Grossi CM; Chan WY; Loke YK; Savva GM; Haroulis C; Steel N; Fox C; Maidment ID; Arthur AJ; Myint PK; Smith TO; Robinson L; Matthews FE; Brayne C; Richardson K
Age Ageing; 2020 Oct; 49(6):939-947. PubMed ID: 32603415
[TBL] [Abstract][Full Text] [Related]
7. Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study.
Green AR; Reifler LM; Bayliss EA; Weffald LA; Boyd CM
Drugs Aging; 2019 Mar; 36(3):289-297. PubMed ID: 30652263
[TBL] [Abstract][Full Text] [Related]
8. Polypharmacy, drug-drug interactions, anticholinergic burden and cognitive outcomes: a snapshot from a community-dwelling sample of older men and women in northern Italy.
Perdixi E; Cotta Ramusino M; Costa A; Bernini S; Conti S; Jesuthasan N; Severgnini M; Prinelli F;
Eur J Ageing; 2024 Mar; 21(1):11. PubMed ID: 38551689
[TBL] [Abstract][Full Text] [Related]
9. Long-term anticholinergic use and the aging brain.
Cai X; Campbell N; Khan B; Callahan C; Boustani M
Alzheimers Dement; 2013 Jul; 9(4):377-85. PubMed ID: 23183138
[TBL] [Abstract][Full Text] [Related]
10. Association of Polypharmacy With Mild Cognitive Impairment and Cognitive Ability: A Nationwide Survey in Taiwan.
Cheng CM; Chang WH; Chiu YC; Sun Y; Lee HJ; Tang LY; Wang PN; Chiu MJ; Yang CH; Tsai SJ; Tsai CF
J Clin Psychiatry; 2018 Sep; 79(6):. PubMed ID: 30256550
[TBL] [Abstract][Full Text] [Related]
11. Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden.
Green AR; Reifler LM; Boyd CM; Weffald LA; Bayliss EA
Drugs Aging; 2018 Mar; 35(3):223-232. PubMed ID: 29404965
[TBL] [Abstract][Full Text] [Related]
12. Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care.
Campbell NL; Lane KA; Gao S; Boustani MA; Unverzagt F
Pharmacotherapy; 2018 May; 38(5):511-519. PubMed ID: 29600808
[TBL] [Abstract][Full Text] [Related]
13. Potentially Inappropriate Medications and Polypharmacy: A Study of Older People with Mild Cognitive Impairment and Mild Dementia.
Bonfiglio V; Umegaki H; Kuzuya M
J Alzheimers Dis; 2019; 71(3):889-897. PubMed ID: 31450496
[TBL] [Abstract][Full Text] [Related]
14. Association of Anticholinergic Drug Burden with Cognitive and Functional Decline Over Time in Older Inpatients: Results from the CRIME Project.
Brombo G; Bianchi L; Maietti E; Malacarne F; Corsonello A; Cherubini A; Ruggiero C; Onder G; Volpato S
Drugs Aging; 2018 Oct; 35(10):917-924. PubMed ID: 30191516
[TBL] [Abstract][Full Text] [Related]
15. How do cognitive and functional impairment relate to the use of anticholinergic medications in hospitalised patients aged 65 years and over?
Kusljic S; Woolley A; Lowe M; Manias E
Aging Clin Exp Res; 2020 Mar; 32(3):423-431. PubMed ID: 31124057
[TBL] [Abstract][Full Text] [Related]
16. Potentially inappropriate medication use and mortality in patients with cognitive impairment.
Buckley E; Jonsson A; Flood Z; Lavelle M; O'Sullivan N; Nurdin N; Dowling P; Duggan E; Callaly E; Byrne C; McGreevy C; Duggan J; Kyne L; McCabe JJ
Eur J Clin Pharmacol; 2022 Dec; 78(12):2013-2020. PubMed ID: 36329311
[TBL] [Abstract][Full Text] [Related]
17. Effect of polypharmacy, potentially inappropriate medications and anticholinergic burden on clinical outcomes: a retrospective cohort study.
Lu WH; Wen YW; Chen LK; Hsiao FY
CMAJ; 2015 Mar; 187(4):E130-E137. PubMed ID: 25646290
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
